As the life sciences (pharmaceuticals, biotechnology and medical sectors) M&A reaches new heights, there seems to be no end in sight for life sciences companies' hunger for acquisitions. 94% of life sciences companies are planning to make an acquisition in the next year, with 91% of US respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket.
The
Read More
patient population
3 Steps to Developing the Right Population Health Management Programs
Cynthia Kilroy, senior vice president of Provider Strategy and Business Development at OptumHealth discusses 3 required steps to developing the right population health management programs
Read More
